To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparable efficacy with etoricoxib 30mg and ibuprofen 2400mg in treating hip or knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2013

Comparable efficacy with etoricoxib 30mg and ibuprofen 2400mg in treating hip or knee OA

Vol: 2| Issue: 7| Number:86| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis

Osteoarthritis Cartilage. 2007 Dec;15(12):1348-56. Epub 2007 Jul 16

Contributing Authors:
A Puopolo JA Boice JL Fidelholtz TW Littlejohn P Miranda A Berrocal A Ko N Cichanowitz AS Reicin

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

548 patients with osteoarthritis (OA) of the knee or hip were randomized to receive one of two treatments. The first group took etoricoxib (30 mg) once a day and the second group took ibuprofen (800 mg) three times a day (for a total of 2400 mg).The co-primary outcomes were pain, function and patient global assessment. Results indicated that there was comparable efficacy between the etoricoxib (30...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue